
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **KRT14, KRT17, KRT6A, KRT6B, KRT5**: These are keratins, which are structural proteins typically expressed in epithelial cells, particularly in basal and myoepithelial cells of the breast.<br>- **SERPINB5 (Maspin)**: A serine protease inhibitor involved in tumor suppression, often associated with epithelial cells.<br>- **S100P, S100A9**: Members of the S100 family of proteins, often involved in calcium binding and associated with epithelial cells and inflammation.<br>- **MMP7**: Matrix metalloproteinase involved in the breakdown of extracellular matrix, often expressed in epithelial cells and associated with cancer progression.<br>- **SOX9**: A transcription factor involved in the regulation of development and differentiation, often expressed in basal epithelial cells.<br>- **CLDN4**: Claudin 4, a component of tight junctions in epithelial cells.<br>- **SLPI**: Secretory leukocyte protease inhibitor, involved in immune response and often expressed in epithelial tissues.<br>- **RARRES1**: Retinoic acid receptor responder, involved in cell differentiation and often expressed in epithelial cells.<br>- **CHI3L1**: Chitinase 3-like 1, involved in tissue remodeling and inflammation, often expressed in epithelial cells.<br>- **CDKN2A**: Cyclin-dependent kinase inhibitor, involved in cell cycle regulation, often associated with tumor suppression in epithelial cells.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT14, KRT17, KRT5**: Strong markers for basal epithelial cells, particularly in the breast.<br>- **KRT6A, KRT6B**: Often expressed in proliferating epithelial cells, including those in the basal layer.<br>- **SOX9**: Associated with stem/progenitor cells in the basal layer of the breast epithelium.<br>- **SERPINB5**: Often expressed in myoepithelial and basal-like breast cancer cells.<br>- **CLDN4**: Commonly expressed in epithelial cells, including those in the breast.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer and epithelial cell markers, the expression of these markers is consistent with basal epithelial cells, particularly those in the breast tissue.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of keratins (KRT14, KRT17, KRT5) and other markers like SOX9 and SERPINB5, the most probable general cell type is **basal epithelial cells**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Basal/Myepithelial Cells**: Given the strong expression of KRT14, KRT17, and KRT5, these are likely basal/myoepithelial cells, which are common in the breast tissue.<br>2. **Basal-like Breast Cancer Cells**: The presence of SERPINB5 and other markers associated with basal-like breast cancer suggests this as a possible subtype.<br>3. **Progenitor Basal Cells**: The expression of SOX9 and other proliferation-associated markers suggests a progenitor or stem-like basal cell type.<br><br>The most likely subtype, based on the markers, is **Basal/Myepithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of basal epithelial cells. The expression of key keratins (KRT14, KRT17, KRT5) and other markers like SOX9 and SERPINB5 supports this annotation. The top three probable subtypes are basal/myoepithelial cells, basal-like breast cancer cells, and progenitor basal cells, with basal/myoepithelial cells being the most likely subtype.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The key functional markers and cell type markers listed in the annotation (KRT14, KRT17, KRT6A, KRT6B, KRT5, SERPINB5, S100P, S100A9, MMP7, SOX9, CLDN4, SLPI, RARRES1, CHI3L1, CDKN2A) are all present in the provided marker list.<br>   - These markers are consistent with basal epithelial cells, particularly in the context of breast tissue, as they are known to be expressed in basal/myoepithelial cells and associated with basal-like breast cancer.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as basal/myoepithelial cells, basal-like breast cancer cells, and progenitor basal cells. This is appropriate given the expression of markers like SERPINB5 and SOX9, which can indicate different subpopulations within the basal epithelial category.<br><br>Overall, the annotation is well-supported by the marker list and the context provided, and the analysis correctly identifies basal/myoepithelial cells as the most likely subtype.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Basal Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Basal/Myepithelial Cells</li><li>Basal-like Breast Cancer Cells</li><li>Progenitor Basal Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its relevance to the cell types in question. The analysis correctly identifies basal epithelial cells as the main cell type, which is consistent with the expression of key keratins (KRT14, KRT17, KRT5) and other markers like SOX9 and SERPINB5. These markers are well-known to be associated with basal/myoepithelial cells in breast tissue, which supports the primary annotation.<br><br>The annotation process shows a balanced consideration of multiple markers, rather than over-focusing on a specific one. For instance, the inclusion of markers like MMP7, CLDN4, and CDKN2A, which are involved in various cellular processes such as matrix remodeling, tight junction formation, and cell cycle regulation, respectively, indicates a comprehensive approach to understanding the cell population.<br><br>The analysis also considers the possibility of mixed cell types by identifying potential subtypes such as basal-like breast cancer cells and progenitor basal cells. This is appropriate given the expression of markers like SERPINB5 and SOX9, which can indicate different subpopulations within the basal epithelial category. This consideration of subtypes adds depth to the annotation and reflects an understanding of the complexity of breast cancer cell populations.<br><br>However, while the annotation is generally accurate, it could benefit from a more explicit discussion of the rank and importance of the markers. The markers listed first, such as KRT14 and KRT17, are indeed crucial for identifying basal epithelial cells, but the analysis could have emphasized their primary importance more clearly. Additionally, while the annotation history mentions the use of databases for cross-referencing, it would be beneficial to see more explicit references to specific studies or data that support the conclusions drawn.<br><br>Overall, the annotation is scientifically accurate, well-balanced in its use of markers, and provides a comprehensive view of the cell types present. There are no obvious misclassifications or oversights, and the analysis captures the general picture of the cell populations effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    